Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2017, Article ID 2353729, 12 pages
https://doi.org/10.1155/2017/2353729
Research Article

Increased Oxidative Damage of RNA in Early-Stage Nephropathy in db/db Mice

1The MOH Key Laboratory of Geriatrics, Beijing Hospital, National Center of Gerontology, Beijing 100730, China
2Department of Laboratory Medicine, Gansu Provincial Hospital, Lanzhou, Gansu 730000, China
3Graduate School, Chinese Academy of Medical Sciences and Peking Union Medical College, Dongdan, Beijing 100730, China
4Department of Clinical Pharmacy, The People’s Hospital of Lishui, Lishui 323000, China
5Department of Clinical Pharmacy, Ningbo Medical Center Lihuili Eastern Hospital, Ningbo 315000, China
6Department of Nephrology, Beijing Hospital, Ministry of Health, Beijing 100730, China
7Department of Laboratory Medicine, Beijing Hospital of the Ministry of Health, Beijing 100730, China
8Department of Pharmacology, Wenzhou Medical University, University Town, Wenzhou, Zhejiang 325035, China

Correspondence should be addressed to Jian-Ping Cai; moc.anis.piv@16pjiac

Received 15 May 2017; Revised 3 September 2017; Accepted 12 September 2017; Published 19 October 2017

Academic Editor: Aiqing Li

Copyright © 2017 Wan-Xia Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. Reidy, H. M. Kang, T. Hostetter, and K. Susztak, “Molecular mechanisms of diabetic kidney disease,” The Journal of Clinical Investigation, vol. 124, pp. 2333–2340, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Afkarian, M. C. Sachs, B. Kestenbaum et al., “Kidney disease and increased mortality risk in type 2 diabetes,” Journal of the American Society of Nephrology, vol. 24, pp. 302–308, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. S. S. Badal and F. R. Danesh, “New insights into molecular mechanisms of diabetic kidney disease,” American Journal of Kidney Diseases, vol. 63, pp. S63–S83, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. G. W. Xu, Q. H. Yao, Q. F. Weng, B. L. Su, X. Zhang, and J. H. Xiong, “Study of urinary 8-hydroxydeoxyguanosine as a biomarker of oxidative DNA damage in diabetic nephropathy patients,” Journal of Pharmaceutical and Biomedical Analysis, vol. 36, pp. 101–104, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. T. Nishikawa, T. Sasahara, S. Kiritoshi et al., “Evaluation of urinary 8-hydroxydeoxy-guanosine as a novel biomarker of macrovascular complications in type 2 diabetes,” Diabetes Care, vol. 26, pp. 1507–1512, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. Y. Hinokio, S. Suzuki, M. Hirai, C. Suzuki, M. Suzuki, and T. Toyota, “Urinary excretion of 8-oxo-7, 8-dihydro-2-deoxyguanosine as a predictor of the development of diabetic nephropathy,” Diabetologia, vol. 45, pp. 877–882, 2002. View at Publisher · View at Google Scholar
  7. Y. Hinokio, S. Suzuki, M. Hirai, M. Chiba, A. Hirai, and T. Toyota, “Oxidative DNA damage in diabetes mellitus: its association with diabetic complications,” Diabetologia, vol. 42, pp. 995–998, 1999. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Serdar, E. Sertoglu, M. Uyanik et al., “Comparison of 8-hydroxy-2-deoxyguanosine (8-OHdG) levels using mass spectrometer and urine albumin creatinine ratio as a predictor of development of diabetic nephropathy,” Free Radical Research, vol. 46, pp. 1291–1295, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. Y. Chang, Q. Kong, X. Shan et al., “Messenger RNA oxidation occurs early in disease pathogenesis and promotes motor neuron degeneration in ALS,” PLoS One, vol. 3, article e2849, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. X. Shan, Y. Chang, and C. L. Lin, “Messenger RNA oxidation is an early event preceding cell death and causes reduced protein expression,” FASEB Journal, vol. 21, pp. 2753–2764, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. K. Broedbaek, V. Siersma, T. Henriksen et al., “Association between urinary markers of nucleic acid oxidation and mortality in type 2 diabetes: a population-based cohort study,” Diabetes Care, vol. 36, pp. 669–676, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. X. Liu, W. Gan, Y. Zou, and B. Yang, “Elevated levels of urinary markers of oxidative dna and RNA damage in type 2 diabetes with complications,” Oxidative Medicine and Cellular Longevity, vol. 2016, Article ID 4323198, 7 pages, 2016. View at Publisher · View at Google Scholar · View at Scopus
  13. W. X. Wang, S. B. Luo, M. M. Xia et al., “Analysis of the oxidative damage of DNA, RNA, and their metabolites induced by hyperglycemia and related nephropathy in Sprague Dawley rats,” Free Radical Research, vol. 49, pp. 1–31, 2015. View at Publisher · View at Google Scholar · View at Scopus
  14. F. C. Brosius 3rd, C. E. Alpers, E. P. Bottinger et al., “Mouse models of diabetic nephropathy,” Journal of the American Society of Nephrology, vol. 20, pp. 2503–2512, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. M. D. Breyer, E. Bottinger, F. C. Brosius 3rd et al., “Mouse models of diabetic nephropathy,” Journal of the American Society of Nephrology, vol. 16, pp. 27–45, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. W. Gan, B. Nie, F. Shi et al., “Age-dependent increases in the oxidative damage of DNA, RNA, and their metabolites in normal and senescence-accelerated mice analyzed by LC–MS/MS: Urinary 8-oxoguanosine as a novel biomarker of aging,” Free Radical Biology & Medicine, vol. 52, pp. 1700–1707, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. J. M. Teiken, P. N. Epstein, and E. C. Carlson, “TEM stereometric analyses of glomeruli in aging OVE26 transgenic diabetic mice,” American Journal of Nephrology, vol. 33, Supplement 1, pp. 8–14, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. S. H. Sung, F. N. Ziyadeh, A. Wang, P. E. Pyagay, Y. S. Kanwar, and S. Chen, “Blockade of vascular endothelial growth factor signaling ameliorates diabetic albuminuria in mice,” Journal of the American Society of Nephrology, vol. 17, pp. 3093–3104, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. European Standards Committee on Oxidative DNA Damage (ESCODD), “Measurement of DNA oxidation in human cells by chromatographic and enzymic methods,” Free Radical Biology & Medicine, vol. 34, pp. 1089–1099, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Yoshida, T. Hashimoto, M. Kihara et al., “Urinary oxidative stress markers closely reflect the efficacy of candesartan treatment for diabetic nephropathy,” Nephron Experimental Nephrology, vol. 111, pp. e20–e30, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Prabhakar, J. Starnes, S. Shi, B. Lonis, and R. Tran, “Diabetic nephropathy is associated with oxidative stress and decreased renal nitric oxide production,” Journal of the American Society of Nephrology, vol. 18, pp. 2945–2952, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Kakimoto, T. Inoguchi, T. Sonta et al., “Accumulation of 8-hydroxy-2-deoxyguanosine and mitochondrial DNA deletion in kidney of diabetic rats,” Diabetes, vol. 51, pp. 1588–1595, 2002. View at Publisher · View at Google Scholar
  23. P. Rossner Jr., H. Orhan, G. Koppen et al., “Urinary 8-oxo-7,8-dihydro-2-deoxyguanosine analysis by an improved ELISA: an inter-laboratory comparison study,” Free Radical Biology & Medicine, vol. 95, pp. 169–179, 2016. View at Publisher · View at Google Scholar · View at Scopus
  24. H. E. Poulsen, L. L. Nadal, K. Broedbaek, P. E. Nielsen, and A. Weimann, “Detection and interpretation of 8-oxodG and 8-oxoGua in urine, plasma and cerebrospinal fluid,” Biochimica et Biophysica Acta (BBA) - General Subjects, vol. 1840, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. C. W. Hu, M. R. Chao, and C. H. Sie, “Urinary analysis of 8-oxo-7,8-dihydroguanine and 8-oxo-7,8-dihydro-2-deoxyguanosine by isotope-dilution LC-MS/MS with automated solid-phase extraction: Study of 8-oxo-7,8-dihydroguanine stability,” Free Radical Biology & Medicine, vol. 48, pp. 89–97, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. R. Andreoli, P. Manini, G. De Palma et al., “Quantitative determination of urinary 8-oxo-7,8-dihydro-2-deoxyguanosine, 8-oxo-7,8-dihydroguanine, 8-oxo-7,8-dihydroguanosine, and their non-oxidized forms: daily concentration profile in healthy volunteers,” Biomarkers, vol. 15, pp. 221–231, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Weimann, D. Belling, and H. E. Poulsen, “Quantification of 8-oxo-guanine and guanine as the nucleobase, nucleoside and deoxynucleoside forms in human urine by high-performance liquid chromatography-electrospray tandem mass spectrometry,” Nucleic Acids Research, vol. 30, article E7, 2002. View at Publisher · View at Google Scholar
  28. R. J. Macisaac, E. I. Ekinci, and G. Jerums, “Markers of and risk factors for the development and progression of diabetic kidney disease,” American Journal of Kidney Diseases, vol. 63, pp. S39–S62, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. H. E. Poulsen, E. Specht, K. Broedbaek et al., “RNA modifications by oxidation: a novel disease mechanism?” Free Radical Biology & Medicine, vol. 52, pp. 1353–1361, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. K. Broedbaek, R. Ribel-Madsen, T. Henriksen et al., “Genetic and environmental influences on oxidative damage assessed in elderly Danish twins,” Free Radical Biology & Medicine, vol. 50, pp. 1488–1491, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. K. Broedbaek, V. Siersma, T. Henriksen et al., “Urinary markers of nucleic acid oxidation and long-term mortality of newly diagnosed type 2 diabetic patients,” Diabetes Care, vol. 34, pp. 2594–2596, 2011. View at Publisher · View at Google Scholar · View at Scopus